Skip to main content

CAP TODAY/Celgene Webinar: Characterizing the Molecular Heterogeneity of Acute Myeloid Leukemia

Thank you

This live web event has ended. Thank you for attending.

Description



Characterizing the Molecular
Heterogeneity of Acute Myeloid Leukemia

Why should you register now for this webinar?
Characterizing the Molecular Heterogeneity of Acute Myeloid Leukemia
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Jay Patel, MD*, and Thomas Leblanc, MD*
*Drs. Patel and LeBlanc are paid speakers for Celgene

Learning Objectives:

  • Review the molecular heterogeneity of acute myeloid leukemia (AML)
  • Assess the clinical implications of somatic mutations in patients with AML
  • Highlight the importance of molecular testing in patients with AML
Ask questions of our distinguished presenter

Pursuant to PhRMA Code on Interactions with Healthcare Professionals, attendance at this promotional program is restricted to healthcare professionals. Accordingly, spouses and other guests who are not healthcare professionals may not attend this event. This is a promotional program and no CME credits are offered.

This is a Celgene sponsored promotional program. CAP TODAY does not endorse any of the products or services named within.
©2019 Celgene Corporation 03/19 US-CLG-19-0266

Contributors

  • Bob McGonnagle

    Publisher, CAP TODAY

  • Jay L. Patel, MD, MBA

    Associate Professor of Pathology University of Utah Medical Director, ARUP Laboratories

  • Thomas LeBlanc, MD

    Associate Professor of Medicine
    Member of the Duke Cancer Institute

April 11, 2019
Thu 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
support@blueskyelearn.com
+1 (858) 201-4136